Apontis Pharma AG APPH.DE
€11.00
Last Updated: Nov 14, 12:00 AM·XETRA
APPH.DE Shariah Compliance
Screening Methodology: AAOIFI
UNLOCK FOR FREE
Last Updated: July 19, 2025
Report Source: 2024 Annual Report
Apontis Pharma AG. Stock Analysis APPH.DE
Germany Health Care Micro Cap Report: APONTIS PHARMA AG engages in the development, promotion, and sale of single pills and other pharmaceutical products. The company is headquartered in Monheim Am Rhein, Nordrhein-Westfalen and currently employs 137 full-time employees. The company went IPO on 2021-05-11. The firm focuses on the commercialization of pharmaceutical products to General Practitioners and engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany.
Read More Key Statistics of Apontis Pharma AG (APPH.DE)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
€11.00Volume
6863.00P/E Ratio (TTM)
124.6752 Week Range
Market Cap
92.65MAvg. Volume
5205.80Dividend Yield
-Financial Metrics & Statements of Apontis Pharma AG (APPH.DE)
FAQ's for Apontis Pharma AG (APPH.DE)
- According to Musaffa’s Shariah screening methodology, Apontis Pharma AG (APPH.DE) is currently classified as HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
Related Halal Stocks to Apontis Pharma AG (APPH.DE)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
